Oncologic Fidelity of Minimally Invasive Surgery to Resect Neoadjuvant-Treated Wilms Tumors.
Katlyn G McKayMuhammad O Abdul GhaniGabriella L CraneParker T EvansShilin ZhaoLaura Y MartinJohn C ThomasHernan CorreaDaniel J BenedettiHarold N LovvornPublished in: The American surgeon (2022)
After neoadjuvant chemotherapy for WT, MIS partial and radical nephrectomies achieved equivalent oncologic fidelity, reduced epidural use and post-operative stays, and better maintained adjuvant therapy timelines when compared to open resections.